Please cite this article in press Muhammad Syed Yasoob Ali Naqvi et al, The Effects Of Smoking Induced Oxidative Stress On Bone Turnover., Indo Am. J. P. Sci, 2021; 08(9).

1. Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis. 2009; 205(1): 23-32.
2. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011; 378(9795): 1015-26.
3. Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009; 9(5): 377-84.
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2019 report. 2019.
5. Vestergaard P, Mosekilde L. Fracture risk associated with smoking: a meta-analysis. Journal of internal medicine. 2003; 254(6): 572-83.
6. Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int. 2012; 23(8): 2081-92.
7. Bender D J-KT, Biglari B, Swing T, et al. Cigarette smoking and its impact on fracture healing. Trauma. 2014.
8. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. The Journal of clinical endocrinology and metabolism. 2000; 85(2): 590-6.
9. Tamaki J, Iki M, Fujita Y, et al. Impact of smoking on bone mineral density and bone metabolism in elderly men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int. 2011; 22(1): 133-41.
10. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcified tissue international. 2001; 68(5): 259-70.
11. Daniel M, Martin AD, Drinkwater DT. Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcified tissue international. 1992; 50(4): 300-5.
12. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. European journal of endocrinology. 2005; 152(4): 491-9.
13. The Health Consequences of Smoking: A Report of the Surgeon General. Reports of the Surgeon General. Atlanta (GA). 2004.
14. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. Bmj. 1997; 315(7112): 841-6.
15. IARC International agency for reasearch on cancer. World Health Organization L. Tobacco smoke and involuntary smoking, IARC. 2002.
16. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005; 111(20): 2684-98.
17. Chan-Yeung M, Dimich-Ward H. Respiratory health effects of exposure to environmental tobacco smoke. Respirology. 2003; 8(2): 131-9.
18. Blum M, Harris SS, Must A, et al. Household tobacco smoke exposure is negatively associated with premenopausal bone mass. Osteoporos Int. 2002; 13(8): 663-8.
19. Afghani A, Xie B, Wiswell RA, et al. Bone mass of asian adolescents in China: influence of physical activity and smoking. Medicine and science in sports and exercise. 2003; 35(5): 720-9.
20. Altunbayrak O, Saridogan M, Ateser B, et al. Passive smoking and postmenopausal osteoporosis. Bone. 2009.
21. Hsu YH BM, Venners SA, Terwedow H, et al. Second-hand smoking increases the risks of osteoporosis and osteoporotic fractures in Chinese men and women. 7th International Symposium on Osteoporosis. 2006.
22. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annual review of nutrition. 2007; 27: 363-88.
23. Braun M, Klingelhöfer D, Oremek GM, et al. Influence of SecondHand Smoke and Prenatal Tobacco Smoke Exposure on Biomarkers, Genetics and Physiological Processes in Children-An Overview in Research Insights of the Last Few Years. Int J Environ Res Public Health. 2020; 17(9): 3212.
24. von Ehrenstein OS, von Mutius E, Maier E, et al. Lung function of school children with low levels of alpha1-antitrypsin and tobacco smoke exposure. The European respiratory journal. 2002; 19(6): 1099-106.
25. Gilliland FD, Li YF, Dubeau L, et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med. 2002; 166(4): 457-63.
26. Kabesch M, Hoefler C, Carr D, et al. Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax. 2004; 59(7): 569-73.
27. Chen Y, Wong GW, Li J. Environmental Exposure and Genetic Predisposition as Risk Factors for Asthma in China. Allergy, asthma & immunology research. 2016; 8(2): 92-100.
28. Cusano NE. Skeletal Effects of Smoking. Current osteoporosis reports. 2015; 13(5): 302-9.
29. Al-Bashaireh AM, Haddad LG, Weaver M, et al. The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms. Journal of osteoporosis. 2018; 2018: 1206235.
30. Hsieh MM, Everhart JE, Byrd-Holt DD, et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Annals of internal medicine. 2007; 146(7): 486-92.
31. Wallace AM, Sandford AJ, English JC, et al. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. Copd. 2008; 5(1): 13-23.
32. Ito JT, Lourenco JD, Righetti RF, et al. Extracellular Matrix Component Remodeling in Respiratory Diseases: What Has Been Found in Clinical and Experimental Studies? Cells. 2019; 8(4): 342.
33. van der Vaart H, Postma DS, Timens W, et al. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax. 2004; 59(8): 713-21.
34. Carnevali S, Petruzzelli S, Longoni B, et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2003; 284(6): L955-63.
35. Chen F, Osterman AL, Mahony K. Smoking and bony union after ulnashortening osteotomy. American journal of orthopedics. 2001; 30(6): 486-9.
36. Little CP, Burston BJ, Hopkinson-Woolley J, et al. Failure of surgery for scaphoid non-union is associated with smoking. Journal of hand surgery. 2006; 31(3): 252-5.
37. Javed F, Rahman I, Romanos GE. Tobacco-product usage as a risk factor for dental implants. Periodontol 2000. 2019; 81(1): 48-56.
38. Pizzino G, Irrera N, Cucinotta M, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxidative medicine and cellular longevity. 2017; 2017: 8416763.
39. B. Halliwell and J. M. C. Gutteridge. Free Radicals in Biology and Medicine. Clarendon Press, Oxford, UK, 4th edition, 2007.
40. T. Bahorun MAS, V. Luximon-Ramma, O. I. Aruoma. Free radicals and antioxidants in cardiovascular health and disease. Internet Journal of Medical Update. 2006; 1: pp 1-17.
41. P. Pacher JSB, L. Liaudet. Nitric oxide and peroxynitrite in health and disease Physiological Reviews. 2007; 87: 315-424.
42. S. Kumar and A. K. Pandey. Free radicals: health implications and their mitigation by herbals. British Journal of Medicine and Medical Research. 2015; 7: 438-57.
43. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. The Scientific World Journal. 2013.
44. Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Critical reviews in food science and nutrition. 2004; 44(4): 275-95.
45. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Current medicinal chemistry. 2005; 12(10): 1161-208.
46. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cellular signalling. 2007; 19(9): 1807-19.
47. Deponte M. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochimica et biophysica acta. 2013; 1830(5): 3217-66.
48. Boskey AL, Posner AS. Bone structure, composition, and mineralization. The Orthopedic clinics of North America. 1984; 15(4): 597-612.
49. Blair HC, Kahn AJ, Crouch EC, et al. Isolated osteoclasts resorb the organic and inorganic components of bone. The Journal of cell biology. 1986; 102(4): 1164-72.
50. Bellido T. Osteocyte-driven bone remodeling. Calcified tissue international. 2014; 94(1): 25-34.
51. Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011; 26(2): 229-38.
52. Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017; 14(2): 209-16.
53. Chen JR, Lazarenko OP, Zhang J, et al. Diet-derived phenolic acids regulate osteoblast and adipocyte lineage commitment and differentiation in young mice. J Bone Miner Res. 2014; 29(5): 104353.
54. Vega D, Maalouf NM, Sakhaee K. CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/ osteoprotegerin: clinical implications. J Clin Endocrinol Metab. 2007; 92(12): 4514-21.
55. Roodman GD. Cell biology of the osteoclast. Experimental hematology. 1999; 27(8): 1229-41.
56. Roodman GD. Regulation of osteoclast differentiation. Annals of the New York Academy of Sciences. 2006; 1068: 100-9.
57. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proceedings of the National Academy of Sciences of the United States of America. 1990; 87(12): 4828-32.
58. Brylka LJ, Schinke T. Chemokines in Physiological and Pathological Bone Remodeling. Frontiers in immunology. 2019; 10: 2182.
59. Atkins GJ, Welldon KJ, Holding CA, et al. The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials. 2009; 30(22): 3672-81.
60. Burguet A, Kaminski M, Abraham-Lerat L, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the Epipage study. BJOG: an international journal of obstetrics and gynaecology. 2004; 111(3): 258-65.
61. Eghbali-Fatourechi G, Khosla S, Sanyal A, et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. The Journal of clinical investigation. 2003; 111(8): 1221-30.
62. Demir B, Haberal A, Geyik P, et al. Identification of the risk factors for osteoporosis among postmenopausal women. Maturitas. 2008; 60(34): 253-6.
63. Fuller K, Wong B, Fox S, et al. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. The Journal of experimental medicine. 1998; 188(5): 997-1001.
64. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397(6717): 315-23.
65. Wang XF, Zhang YK, Yu ZS, et al. The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. Molecular medicine reports. 2013; 7(4): 1169-72.
66. LaCroix AZ, Jackson RD, Aragaki A, et al. OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women’s Health Initiative Observational Study. Bone. 2013; 56(2): 474-81.
67. Lee NK, Choi YG, Baik JY, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood. 2005; 106(3): 852-9.
68. Ha H, Kwak HB, Lee SW, et al. Reactive oxygen species mediate RANK signaling in osteoclasts. Experimental cell research. 2004; 301(2): 119-27.
69. Steinbeck MJ, Kim JK, Trudeau MJ, et al. Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclastlike cells. Journal of cellular physiology. 1998; 176(3): 574-87.
70. Kim HS, Nam ST, Mun SH, et al. DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation. Nature communications. 2017; 8(1): 1519.
71. Kubota M, Yanagita M, Mori K, et al. The Effects of Cigarette Smoke Condensate and Nicotine on Periodontal Tissue in a Periodontitis Model Mouse. PloS one. 2016; 11(5): e0155594.
72. Kim DK, Kim HS, Kim AR, et al. DJ-1 regulates mast cell activation and IgE-mediated allergic responses. The Journal of allergy and clinical immunology. 2013; 131(6): 1653-62.
73. Kim JM, Jang HJ, Choi SY, et al. DJ-1 contributes to adipogenesis and obesity-induced inflammation. Scientific reports. 2014; 4: 4805.
74. Lev N, Barhum Y, Lotan I, et al. DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS. PloS one. 2015; 10(3): e0117190.
75. Won KJ, Jung SH, Jung SH, et al. DJ-1/park7 modulates vasorelaxation and blood pressure via epigenetic modification of endothelial nitric oxide synthase. Cardiovascular research. 2014; 101(3): 473-81.
76. Xu XM, Moller SG. ROS removal by DJ-1: Arabidopsis as a new model to understand Parkinson’s Disease. Plant signaling & behavior. 2010; 5(8): 1034-6.
77. Kinumi T, Kimata J, Taira T, et al. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochemical and biophysical research communications. 2004; 317(3): 722-8.
78. Taira T, Saito Y, Niki T, et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO reports. 2004; 5(2): 213-8.
79. Cuevas S, Zhang Y, Yang Y, et al. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension. 2012; 59(2): 446-52.
80. Murgia D, Mauceri R, Campisi G, et al. Advance on Resveratrol Application in Bone Regeneration: Progress and Perspectives for Use in Oral and Maxillofacial Surgery. Biomolecules. 2019; 9(3): 94.
81. Correa MG, Absy S, Tenenbaum H, et al. Resveratrol attenuates oxidative stress during experimental periodontitis in rats exposed to cigarette smoke inhalation. Journal of periodontal research. 2019; 54(3): 225-32.
82. Lee YJ, Hong JY, Kim SC, et al. The association between oxidative stress and bone mineral density according to menopausal status of Korean women. Obstetrics & gynecology science. 2015; 58(1): 46-52.
83. Ostman B, Michaelsson K, Helmersson J, et al. Oxidative stress and bone mineral density in elderly men: antioxidant activity of alphatocopherol. Free radical biology & medicine. 2009; 47(5): 668-73.
84. Barbosa AP, Lourenco JD, Junqueira JJM, et al. The deleterious effects of smoking in bone mineralization and fibrillar matrix composition. Life sciences. 2020; 241: 117132.
85. Murshed M, Harmey D, Millan JL, et al. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes & development. 2005; 19(9): 1093-104.
86. Ricard-Blum S. The collagen family. Cold Spring Harbor perspectives in biology. 2011; 3(1): a004978.
87. Morello R. Osteogenesis imperfecta and therapeutics. Matrix biology: journal of the International Society for Matrix Biology. 2018; 71-72: 294-312.
88. Sasaki M, Chubachi S, Kameyama N, et al. Effects of long-term cigarette smoke exposure on bone metabolism, structure, and quality in a mouse model of emphysema. PloS one. 2018; 13(1): e0191611.
89. Narisawa S, Yadav MC, Millan JL. In vivo overexpression of tissuenonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res. 2013; 28(7): 1587-98.
90. Knuutinen A, Kokkonen N, Risteli J, et al. Smoking affects collagen synthesis and extracellular matrix turnover in human skin. The British journal of dermatology. 2002; 146(4): 588-94.
91. Sorensen LT, Zillmer R, Agren M, et al. Effect of smoking, abstention, and nicotine patch on epidermal healing and collagenase in skin transudate. Wound Repair Regen. 2009; 17(3): 347-53.
92. Zhang Y, Xiong Y, Zhou J, et al. FoxO1 expression in osteoblasts modulates bone formation through resistance to oxidative stress in mice. Biochemical and biophysical research communications. 2018; 503(3): 1401-8.
93. Lee JJ, Patel R, Biermann JS, et al. The musculoskeletal effects of cigarette smoking. The Journal of bone and joint surgery American volume. 2013; 95(9): 850-9.
94. Carlson BB, Burton DC, Jackson RS, et al. Recidivism Rates After Smoking Cessation Before Spinal Fusion. Orthopedics. 2016; 39(2): e318-22.
95. Wong PK, Christie JJ, Wark JD. The effects of smoking on bone health. Clinical science. 2007; 113(5): 233-41.
96. Kim KH, Lee CM, Park SM, et al. Secondhand smoke exposure and osteoporosis in never-smoking postmenopausal women: the Fourth Korea National Health and Nutrition Examination Survey. Osteoporos Int. 2013; 24(2): 523-32.
97. Ko CH, Chan RL, Siu WS, et al. Deteriorating effect on bone metabolism and microstructure by passive cigarette smoking through dual actions on osteoblast and osteoclast. Calcified tissue international. 2015; 96(5): 389-400.
98. Ajiro Y, Tokuhashi Y, Matsuzaki H, et al. Impact of passive smoking on the bones of rats. Orthopedics. 2010; 33(2): 90-5.
99. Zhou Q, Zhu L, Zhang D, et al. Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and MetaAnalyses. Disease markers. 2016; 2016: 7067984.
100. Sanchez-Rodriguez MA, Ruiz-Ramos M, Correa-Munoz E, et al. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC musculoskeletal disorders. 2007; 8: 124.
101. Basu S, Michaelsson K, Olofsson H, et al. Association between oxidative stress and bone mineral density. Biochemical and biophysical research communications. 2001; 288(1): 275-9.
102. Leboff MS, Narweker R, LaCroix A, et al. Homocysteine levels and risk of hip fracture in postmenopausal women. The Journal of clinical endocrinology and metabolism. 2009; 94(4): 1207-13.
103. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. The New England journal of medicine. 2004; 350(20): 2042-9.
104. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. The New England journal of medicine. 2004; 350(20): 2033-41.
105. Khan NA, Lawyer G, McDonough S, et al. Systemic biomarkers of inflammation, oxidative stress and tissue injury and repair among waterpipe, cigarette and dual tobacco smokers. Tobacco control. 2020; 29(Suppl 2): s102-s9.